CDEK
← All organizations

Chattem

For profitContributed to NME

Also known as: CHATTEM | Chattem, Inc.

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Nov 1, 2012

First marketed drug

May 17, 1951

First NDA

May 17, 1951

Last known activity

Nov 1, 2012

Acquired by Sanofi-Aventis on Jan 1, 2009

Timeline

1870s

  1. Jan 1, 1879

    Chattem— Founded

1950s

  1. May 17, 1951

    selenium— NDA Organization

1970s

  1. Feb 13, 1978

    doxylamine— NDA Secondary Org

2000s

  1. Jan 1, 2009

    Sanofi-Aventis— Acquired By

Drugs by trial phase (1 distinct, 1 trials)

Phase 3 (1 own, 0 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (2)

Recent trials (1)

Details

Founded
Chattanooga, TN, US Jan 1, 1879
First NDA
May 17, 1951
Last known activity
Nov 1, 2012